Michael Wiederhorn

Stock Analyst at Oppenheimer

(3.61)
# 859
Out of 4,711 analysts
135
Total ratings
51.91%
Success rate
4.81%
Average return

Stocks Rated by Michael Wiederhorn

Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95$85
Current: $59.58
Upside: +42.67%
UnitedHealth Group
Dec 6, 2024
Maintains: Outperform
Price Target: $610$640
Current: $500.13
Upside: +27.97%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34$37
Current: $27.38
Upside: +35.14%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390$400
Current: $303.62
Upside: +31.74%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165$168
Current: $134.59
Upside: +24.82%
Humana
Oct 3, 2024
Maintains: Outperform
Price Target: $400$280
Current: $247.10
Upside: +13.31%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140$145
Current: $131.40
Upside: +10.35%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32$40
Current: $13.01
Upside: +207.46%
Teladoc Health
Aug 1, 2024
Maintains: Outperform
Price Target: $21$17
Current: $9.44
Upside: +80.08%
Community Health Systems
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5$5
Current: $3.16
Upside: +58.23%
Maintains: Outperform
Price Target: $370$400
Current: $276.92
Upside: +44.45%
Maintains: Perform
Price Target: n/a
Current: $7.65
Upside: -
Maintains: Outperform
Price Target: $625$650
Current: $523.16
Upside: +24.24%
Maintains: Outperform
Price Target: $175$145
Current: $84.47
Upside: +71.66%